BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2889557)

  • 21. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
    Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
    J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R
    J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-2 and receptor].
    Tagaya Y; Yodoi J
    Nihon Rinsho; 1988 May; 46(5):1002-7. PubMed ID: 3137376
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human interleukin-2 receptor.
    Greene WC; Leonard WJ
    Annu Rev Immunol; 1986; 4():69-95. PubMed ID: 3011033
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro augmentation of interleukin-2 production and lymphocytes with the TAC antigen marker in patients with AIDS.
    Tsang KY; Fudenberg HH; Galbraith GM
    N Engl J Med; 1984 Apr; 310(15):987. PubMed ID: 6199672
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2 receptor dysfunction and adult T-cell leukemia.
    Yodoi J; Uchiyama T
    Immunol Rev; 1986 Aug; 92():135-56. PubMed ID: 2875026
    [No Abstract]   [Full Text] [Related]  

  • 31. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
    Taylor DS; Kern JA; Nowell PC
    J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multichain interleukin-2 receptor: from the gene to the bedside.
    Waldmann TA
    Harvey Lect; 1986-1987; 82():1-17. PubMed ID: 3129378
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of recombinant interleukin-2 on resting human T lymphocytes.
    Hammer SM; Gillis JM
    J Biol Response Mod; 1986 Feb; 5(1):36-44. PubMed ID: 3007679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and expression of complementary DNAs encoding the human interleukin 2 receptor.
    Greene WC; Depper JM; Crabtree GR; Rudikoff S; Pumphrey J; Robb RJ; Krönke M; Svetlik P; Peffer NJ; Waldmann TA
    Cancer Res; 1985 Sep; 45(9 Suppl):4563s-4567s. PubMed ID: 2990688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2: a review.
    Kolitz JE; Welte K; Sykora KW; Mertelsmann R
    Arzneimittelforschung; 1985; 35(10):1607-15. PubMed ID: 3000391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Structure of the human T-lymphotropic virus and biological function--transformation and cytopathic effect].
    Hatanaka M
    Nihon Rinsho; 1986 Oct; 44(10):2130-6. PubMed ID: 2881008
    [No Abstract]   [Full Text] [Related]  

  • 39. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
    Van Wauwe JP; Goossens JG; Beverley PC
    J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.